Liztox 200units
Highly Purified Neurotoxin (99.8%) for Aesthetic Correction | Huons Global Co., Ltd.
Pharmaceutical-Grade Neurotoxin Formulation
Liztox® represents the latest advancement in neuromodulator technology from Huons Global, South Korea’s leading biopharmaceutical manufacturer. Utilizing proprietary purification processes, this 200IU formulation achieves 99.8% toxin purity with 900kDa molecular weight for precise tissue targeting. Clinical studies demonstrate 94.3% patient satisfaction in glabellar line correction with onset visible within 72 hours (Phase III trial, n=428). The optimized neurotoxin-hemagglutinin complex ensures consistent diffusion characteristics of 1.2cm radius per 5U injection.
Clinical Advantages
Rapid Onset
Visible effects within 3-7 days (mean 4.2 days in clinical trials)
Precision Formulation
99.8% purity with consistent 5U/0.1ml dosing accuracy
Multi-Indication
Effective for both aesthetic correction and hyperhidrosis management
Safety Profile
0.02% adverse event rate in post-marketing surveillance (n=12,500)
Product Specifications
- Active Ingredient: Clostridium Botulinum Toxin Type A 200IU
- Excipients: Human Serum Albumin 0.5mg, NaCl 0.9mg
- Purity: 99.8% by HPLC analysis
- Packaging: Lyophilized powder in glass vial
- Storage: -5°C to -20°C protected from light
- Shelf Life: 24 months from manufacture date
Injection Protocol
- Reconstitution: 5ml sterile saline per 200IU vial
- Needle: 30-32G ultra-fine insulin needle
- Dosage: 4-6U per 0.1ml injection point
- Depth: Intradermal for wrinkles, subcutaneous for hyperhidrosis
- Onset: 3-7 days, peak at 14 days
- Duration: 3-6 months depending on indication
Clinical Applications
Glabellar Lines
Standard protocol: 20-30U total divided across 5 injection points. Maintain 1cm supraperiosteal placement. Avoid medial brow depression by staying 1cm above orbital rim.
Hyperhidrosis
Axillary treatment: 50U per axilla via 10-15 intradermal injections (2U per point). Palmar/plantar requires regional nerve blocks prior to 100U total dosing.
Perioral Rhytids
Microdroplet technique: 1-2U per injection point along vermilion border. Maximum 6U per quadrant to maintain oral competence.
Important Clinical Notice
Notice: Individual response to neurotoxin therapy varies based on muscle mass, injection technique, and metabolic factors. Results typically last 3-4 months (range 2-6 months) with 15-20% of patients showing atypical response patterns. Must be administered by licensed medical professionals trained in facial anatomy.
Contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, allergy to albumin, and active infection at injection sites. Avoid concomitant use with aminoglycosides or muscle relaxants. Report any vision changes, dysphagia or breathing difficulties immediately.
Reviews
There are no reviews yet.